Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

PH II GL-0817 (w/ Cyclophosphamide) for Prev of Recur in HLA-A2+ Pts w/ High-Risk SCC of Oral Cavity

Protocol: OSU-16267

Full Title

A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of GL-0817 (with Cyclophosphamide) for the Prevention of Recurrence in HLA-A2+ Patients with High-Risk Squamous Cell Carcinoma of the Oral Cavity

Squamous Cell Carcinoma Skin Cancers